AOXG (Aoxing Pharmaceutical Co) Graham Number: $N/A (As of Mar. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Aoxing Pharmaceutical Co Graham Number?

Aoxing Pharmaceutical Co AOXG Graham Number is $N/A as of Mar. 2017.

Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.

As of today (2026-08-10), the stock price of Aoxing Pharmaceutical Co is $0.0035. Aoxing Pharmaceutical Co's graham number for the quarter that ended in Mar. 2017 was $N/A. Therefore, Aoxing Pharmaceutical Co's Price to Graham Number ratio for today is N/A.

The historical rank and industry rank for Aoxing Pharmaceutical Co's Graham Number or its related term are showing as below:

AOXG's Price-to-Graham-Number is not ranked *
in the Diversified Financial Services industry.
Industry Median: 1.835
* Ranked among companies with meaningful Price-to-Graham-Number only.

Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.


Aoxing Pharmaceutical Co  (OTCPK:AOXG) Graham Number Explanation

Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:

Current price should not be more than 15 times average earnings of the past three years.

Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)

Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.

In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.

Aoxing Pharmaceutical Co's Price to Graham number Ratio for today is calculated as

Price to Graham number=Share Price (Today)/Graham number (Q: Mar. 2017 )
=0.0035/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Please keep these in mind:

1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.


Aoxing Pharmaceutical Co Graham Number Related Terms


Aoxing Pharmaceutical Co Graham Number Historical Data

* Premium members only.

The historical data trend for Aoxing Pharmaceutical Co's Graham Number can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aoxing Pharmaceutical Co Graham Number Chart

Aoxing Pharmaceutical Co Annual Data
Trend Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16
Graham Number
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.56 0.39

Aoxing Pharmaceutical Co Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Graham Number Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.86 0.44 0.35 0.00 0.00

AOXG vs OWCP, BSPK, MYHI: Graham Number Comparison

For the Shell Companies subindustry, Aoxing Pharmaceutical Co's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aoxing Pharmaceutical Co Price-to-Graham-Number vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Aoxing Pharmaceutical Co's Price-to-Graham-Number distribution charts can be found below:

* The bar in red indicates where Aoxing Pharmaceutical Co's Price-to-Graham-Number falls into.



Aoxing Pharmaceutical Co Graham Number Calculation

Graham Number is a concept based on Ben Graham's conservative valuation of companies.

Aoxing Pharmaceutical Co's Graham Number for the fiscal year that ended in Jun. 2016 is calculated as

Graham Number
=sqrt of (22.5* Tangible Book per Share *EPS without NRI)
=sqrt of (22.5*0.226*0.03)
=0.39

Aoxing Pharmaceutical Co's Graham Number for the quarter that ended in Mar. 2017 is calculated as

Graham Number
=sqrt of (22.5*Tangible Book per Share*EPS without NRI (TTM))
=sqrt of (22.5*0.227*-0.015)
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Graham Number →
What does a Graham Number of $N/A mean?
Aoxing Pharmaceutical Co (AOXG) has a Graham Number of $N/A as of Mar. 2017. The Graham Number values a company based on its per-share earnings and book value. View historical data on Aoxing Pharmaceutical Co and its competitors.
Is Aoxing Pharmaceutical Co's Graham Number too high?
Aoxing Pharmaceutical Co's current Graham Number is $N/A.
How does Aoxing Pharmaceutical Co's Graham Number compare to OWCP and BSPK?
Aoxing Pharmaceutical Co's Graham Number of $N/A can be compared against companies in the Diversified Financial Services industry. The industry median Graham Number is 1.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Graham Number for a Diversified Financial Services company?
The median Graham Number among Diversified Financial Services companies is 1.84, based on 292 companies in the industry. Companies in the top quartile (top 25%) have a Graham Number significantly above this median, while those in the bottom quartile fall well below. However, Graham Number should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Graham Number mean?
A high Graham Number can signal that a stock is expensive relative to its fundamentals. The Graham Number values a company based on its per-share earnings and book value. View historical data on Aoxing Pharmaceutical Co and its competitors. For the Diversified Financial Services industry, the median Graham Number is 1.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aoxing Pharmaceutical Co's current Graham Number is $N/A. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aoxing Pharmaceutical Co stock overvalued right now?
Aoxing Pharmaceutical Co (AOXG) has a current Graham Number of $N/A. The current Graham Number is $N/A. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Graham Number calculated?
Graham Number is calculated from a company's financial statements. For Aoxing Pharmaceutical Co (AOXG), the current Graham Number is $N/A as of Mar. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aoxing Pharmaceutical Co Business Description

Address Block 25, Flat F, 9th Floor, South Horizons, Apleichau, Hong Kong, HKG
Aoxing Pharmaceutical Co Inc does not have any business operations and is restructuring for a new business model and plans to acquire an operating company via reverse merger.